myoblast differentiation / Signaling by RAS GAP mutants / Signaling by RAS GTPase mutants / Activation of RAS in B cells / tertiary granule membrane / RAS signaling downstream of NF1 loss-of-function variants / SOS-mediated signalling / Activated NTRK3 signals through RAS / Activated NTRK2 signals through RAS / SHC1 events in ERBB4 signaling ...myoblast differentiation / Signaling by RAS GAP mutants / Signaling by RAS GTPase mutants / Activation of RAS in B cells / tertiary granule membrane / RAS signaling downstream of NF1 loss-of-function variants / SOS-mediated signalling / Activated NTRK3 signals through RAS / Activated NTRK2 signals through RAS / SHC1 events in ERBB4 signaling / Signalling to RAS / SHC-related events triggered by IGF1R / Activated NTRK2 signals through FRS2 and FRS3 / Estrogen-stimulated signaling through PRKCZ / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / SHC-mediated cascade:FGFR2 / PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases / SHC-mediated cascade:FGFR4 / Signaling by FGFR4 in disease / SHC-mediated cascade:FGFR1 / Erythropoietin activates RAS / FRS-mediated FGFR3 signaling / Signaling by FLT3 ITD and TKD mutants / FRS-mediated FGFR2 signaling / FRS-mediated FGFR4 signaling / Signaling by FGFR3 in disease / p38MAPK events / Tie2 Signaling / FRS-mediated FGFR1 signaling / positive regulation of endothelial cell proliferation / Signaling by FGFR2 in disease / GRB2 events in EGFR signaling / SHC1 events in EGFR signaling / EGFR Transactivation by Gastrin / Signaling by FLT3 fusion proteins / FLT3 Signaling / Ras activation upon Ca2+ influx through NMDA receptor / Signaling by FGFR1 in disease / GRB2 events in ERBB2 signaling / NCAM signaling for neurite out-growth / CD209 (DC-SIGN) signaling / SHC1 events in ERBB2 signaling / Downstream signal transduction / Constitutive Signaling by Overexpressed ERBB2 / Insulin receptor signalling cascade / small monomeric GTPase / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / G protein activity / VEGFR2 mediated cell proliferation / FCERI mediated MAPK activation / Signaling by ERBB2 TMD/JMD mutants / RAF activation / Signaling by high-kinase activity BRAF mutants / Constitutive Signaling by EGFRvIII / MAP2K and MAPK activation / Signaling by ERBB2 ECD mutants / Signaling by ERBB2 KD Mutants / Signaling by SCF-KIT / Regulation of RAS by GAPs / Negative regulation of MAPK pathway / RAS processing / Signaling by RAF1 mutants / Signaling by moderate kinase activity BRAF mutants / Paradoxical activation of RAF signaling by kinase inactive BRAF / Signaling downstream of RAS mutants / GDP binding / MAPK cascade / Signaling by BRAF and RAF1 fusions / Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants / DAP12 signaling / RAF/MAP kinase cascade / Ras protein signal transduction / Golgi membrane / GTPase activity / Neutrophil degranulation / protein-containing complex binding / endoplasmic reticulum membrane / GTP binding / Golgi apparatus / extracellular exosome / membrane / plasma membrane / cytosol Similarity search - Function
Small GTPase, Ras-type / small GTPase Ras family profile. / Rho (Ras homology) subfamily of Ras-like small GTPases / Ras subfamily of RAS small GTPases / Small GTPase / Ras family / Rab subfamily of small GTPases / Small GTP-binding protein domain / P-loop containing nucleotide triphosphate hydrolases / P-loop containing nucleoside triphosphate hydrolase ...Small GTPase, Ras-type / small GTPase Ras family profile. / Rho (Ras homology) subfamily of Ras-like small GTPases / Ras subfamily of RAS small GTPases / Small GTPase / Ras family / Rab subfamily of small GTPases / Small GTP-binding protein domain / P-loop containing nucleotide triphosphate hydrolases / P-loop containing nucleoside triphosphate hydrolase / Rossmann fold / 3-Layer(aba) Sandwich / Alpha Beta Similarity search - Domain/homology
Mass: 18.015 Da / Num. of mol.: 84 / Source method: isolated from a natural source / Formula: H2O
-
Experimental details
-
Experiment
Experiment
Method: X-RAY DIFFRACTION / Number of used crystals: 1
-
Sample preparation
Crystal
Density Matthews: 1.78 Å3/Da / Density % sol: 30.89 %
Crystal grow
Temperature: 291 K / Method: vapor diffusion, sitting drop / pH: 8.5 Details: 30.0% PEG 3350, 0.2M Magnesium chloride, 0.1 M Tris-HCl, GDP was added to the concentrated protein to a final concentration of 5mM. Crystallization were set up with 1:100 chymotrypsin, pH 8. ...Details: 30.0% PEG 3350, 0.2M Magnesium chloride, 0.1 M Tris-HCl, GDP was added to the concentrated protein to a final concentration of 5mM. Crystallization were set up with 1:100 chymotrypsin, pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K
Resolution: 1.649→35.967 Å / Cor.coef. Fo:Fc: 0.958 / Cor.coef. Fo:Fc free: 0.945 / WRfactor Rfree: 0.212 / WRfactor Rwork: 0.182 / SU B: 1.746 / SU ML: 0.062 / Cross valid method: THROUGHOUT / σ(F): 0 / ESU R: 0.103 / ESU R Free: 0.102 / Stereochemistry target values: MAXIMUM LIKELIHOOD Details: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. Programs arp/warp, coot, molprobity have also been used in refinement
Rfactor
Num. reflection
% reflection
Selection details
Rfree
0.219
949
5.122 %
RANDOM
Rwork
0.185
-
-
-
obs
0.186
18528
99.16 %
-
Solvent computation
Ion probe radii: 0.8 Å / Shrinkage radii: 0.8 Å / VDW probe radii: 1.2 Å / Solvent model: MASK BULK SOLVENT
Displacement parameters
Biso mean: 19.437 Å2
Baniso -1
Baniso -2
Baniso -3
1-
-0.056 Å2
-0.028 Å2
0 Å2
2-
-
-0.056 Å2
0 Å2
3-
-
-
0.083 Å2
Refinement step
Cycle: LAST / Resolution: 1.649→35.967 Å
Protein
Nucleic acid
Ligand
Solvent
Total
Num. atoms
1216
0
40
84
1340
Refine LS restraints
Refine-ID
Type
Dev ideal
Dev ideal target
Number
X-RAY DIFFRACTION
r_bond_refined_d
0.016
0.022
1267
X-RAY DIFFRACTION
r_bond_other_d
0.002
0.02
827
X-RAY DIFFRACTION
r_angle_refined_deg
1.53
1.991
1726
X-RAY DIFFRACTION
r_angle_other_deg
0.943
3
2029
X-RAY DIFFRACTION
r_dihedral_angle_1_deg
5.722
5
160
X-RAY DIFFRACTION
r_dihedral_angle_2_deg
39.808
24.444
54
X-RAY DIFFRACTION
r_dihedral_angle_3_deg
11.594
15
215
X-RAY DIFFRACTION
r_dihedral_angle_4_deg
14.187
15
7
X-RAY DIFFRACTION
r_chiral_restr
0.091
0.2
203
X-RAY DIFFRACTION
r_gen_planes_refined
0.006
0.02
1392
X-RAY DIFFRACTION
r_gen_planes_other
0.001
0.02
251
X-RAY DIFFRACTION
r_nbd_refined
0.211
0.2
246
X-RAY DIFFRACTION
r_nbd_other
0.204
0.2
906
X-RAY DIFFRACTION
r_nbtor_refined
0.176
0.2
634
X-RAY DIFFRACTION
r_nbtor_other
0.083
0.2
632
X-RAY DIFFRACTION
r_xyhbond_nbd_refined
0.108
0.2
59
X-RAY DIFFRACTION
r_symmetry_vdw_refined
0.128
0.2
8
X-RAY DIFFRACTION
r_symmetry_vdw_other
0.26
0.2
32
X-RAY DIFFRACTION
r_symmetry_hbond_refined
0.115
0.2
14
X-RAY DIFFRACTION
r_mcbond_it
2.396
2
846
X-RAY DIFFRACTION
r_mcbond_other
0.693
2
321
X-RAY DIFFRACTION
r_mcangle_it
3.021
3
1264
X-RAY DIFFRACTION
r_scbond_it
2.846
2
544
X-RAY DIFFRACTION
r_scangle_it
3.879
3
459
LS refinement shell
Refine-ID: X-RAY DIFFRACTION / Total num. of bins used: 20
Resolution (Å)
Rfactor Rfree
Num. reflection Rfree
Rfactor Rwork
Num. reflection Rwork
Num. reflection all
% reflection obs (%)
1.649-1.692
0.347
73
0.266
1175
1392
89.655
1.692-1.738
0.33
56
0.216
1253
1309
100
1.738-1.788
0.24
70
0.195
1212
1290
99.38
1.788-1.843
0.177
75
0.175
1201
1276
100
1.843-1.903
0.201
72
0.171
1134
1206
100
1.903-1.97
0.178
75
0.157
1116
1191
100
1.97-2.044
0.201
56
0.16
1094
1150
100
2.044-2.127
0.224
55
0.162
1046
1101
100
2.127-2.222
0.206
39
0.166
1004
1043
100
2.222-2.33
0.189
36
0.162
977
1013
100
2.33-2.455
0.26
49
0.183
916
965
100
2.455-2.603
0.22
52
0.177
869
921
100
2.603-2.782
0.193
50
0.195
814
864
100
2.782-3.003
0.22
46
0.211
745
791
100
3.003-3.288
0.291
42
0.193
700
742
100
3.288-3.672
0.233
26
0.179
652
678
100
3.672-4.233
0.139
24
0.16
573
598
99.833
4.233-5.166
0.226
20
0.165
489
510
99.804
5.166-7.232
0.223
24
0.241
373
397
100
7.232-35.967
0.222
9
0.246
236
248
98.79
+
About Yorodumi
-
News
-
Feb 9, 2022. New format data for meta-information of EMDB entries
New format data for meta-information of EMDB entries
Version 3 of the EMDB header file is now the official format.
The previous official version 1.9 will be removed from the archive.
In the structure databanks used in Yorodumi, some data are registered as the other names, "COVID-19 virus" and "2019-nCoV". Here are the details of the virus and the list of structure data.
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)
EMDB accession codes are about to change! (news from PDBe EMDB page)
The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
The EM Navigator/Yorodumi systems omit the EMD- prefix.
Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator
Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.
Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi